" /> 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene - CISMeF





Preferred Label : 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene;

MeSH note : intermediate in carcinogenic & mutagenic process; RN given refers to cpd without isomeric designation; structure in first source;

MeSH synonym : benzanthracene 3,4-diol-1,2-epoxide; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzanthracene; 3,4-DETBA;

MeSH CAS label : Benzo(6,7)phenanthro(3,4-b)oxirene-2,3-diol, 1a,2,3,11c-tetrahydro-;

MeSH Related Number : 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aalpha,2alpha,3beta,11calpha)-isomer; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aalpha,2beta,3alpha,11calpha)-( -)-isomer; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aS-(1aalpha,2beta,3alpha,11calpha))-isomer; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aR-(1aalpha,2alpha,3beta,11calpha))-isomer; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aR-(1aalpha,2beta,3alpha,11calpha))-isomer; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aS-(1aalpha,2alpha,3beta,11calpha)-)-isomer; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aalpha,2alpha,3beta,11calpha)-( -)-isomer; 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1alpha,2beta,3alpha,11calpha)-isomer; 63438-26-6 ((1alpha,2beta,3alpha,11calpha)-isomer); 63493-01-6 ((1aalpha,2alpha,3beta,11calpha)-isomer); 64598-80-7 ((1aalpha,2beta,3alpha,11calpha)-( -)-isomer); 64598-81-8 ((1aalpha,2alpha,3beta,11calpha)-( -)-isomer); 80433-78-9 ((1aR-(1aalpha,2alpha,3beta,11calpha))-isomer); 80433-79-0 ((1aS-(1aalpha,2alpha,3beta,11calpha)-)-isomer); 80433-81-4 ((1aR-(1aalpha,2beta,3alpha,11calpha))-isomer); 80446-23-7 ((1aS-(1aalpha,2beta,3alpha,11calpha))-isomer);

Libelles Related CAS CISMeF : acide 6-hydroxynaphtalène-2-sulfonique;

Registry Number MeSH : 64551-89-9;

Related CAS MeSH : 63493-01-6 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aalpha,2alpha,3beta,11calpha)-isomer); 64598-80-7 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aalpha,2beta,3alpha,11calpha)-( -)-isomer); 80446-23-7 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aS-(1aalpha,2beta,3alpha,11calpha))-isomer); 80433-78-9 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aR-(1aalpha,2alpha,3beta,11calpha))-isomer); 80433-81-4 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aR-(1aalpha,2beta,3alpha,11calpha))-isomer); 80433-79-0 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aS-(1aalpha,2alpha,3beta,11calpha)-)-isomer); 64598-81-8 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1aalpha,2alpha,3beta,11calpha)-( -)-isomer); 63438-26-6 (3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene, (1alpha,2beta,3alpha,11calpha)-isomer);

related registry number list (CISMeF) : 63438-26-6 ((1alpha,2beta,3alpha,11calpha)-isomer); 63493-01-6 ((1aalpha,2alpha,3beta,11calpha)-isomer); 64598-80-7 ((1aalpha,2beta,3alpha,11calpha)-( -)-isomer); 64598-81-8 ((1aalpha,2alpha,3beta,11calpha)-( -)-isomer); 80433-78-9 ((1aR-(1aalpha,2alpha,3beta,11calpha))-isomer); 80433-79-0 ((1aS-(1aalpha,2alpha,3beta,11calpha)-)-isomer); 80433-81-4 ((1aR-(1aalpha,2beta,3alpha,11calpha))-isomer); 80446-23-7 ((1aS-(1aalpha,2beta,3alpha,11calpha))-isomer);

Is substance : O;

Details


You can consult :


Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.